Conditions: Acute Demylelinating Optic Neuritis
Keywords: Acute demyelinating optic neuritis Optic neuritis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 2
Healthy volunteers: no

Brief summary:
To evaluate the efficacy and safety of fingolimod 0.5mg versus placebo in patients with suspected acute demyelinating optic neuritis (ADON) receiving standard steroid treatment

Detailed description:

Arms:
arm 1: Oral capsule dose was given once daily for 48 weeks arm 2: Patients received oral dose of placebo from Weeks 0-18, followed by oral dose of fingolimod 0.5/mg capsule from Weeks 18-48

Interventions: intervention 1: Fingolimod 0.5mg/daily intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: